UBS Group’s WisdomTree True Emerging Markets Fund XC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-9
Closed -$281 – 11107
2026
Q1
$281 Sell
9
-99
-92% -$3.26K ﹤0.01% 9980
2025
Q4
$3.5K Sell
108
-1,234
-92% -$42.6K ﹤0.01% 9005
2025
Q3
$46.5K Sell
1,342
-150
-10% -$5.15K ﹤0.01% 7618
2025
Q2
$51.4K Buy
+1,492
New +$47K ﹤0.01% 7746
2023
Q4
– Sell
-985
Closed -$25.8K – 9952
2023
Q3
$25.8K Buy
+985
New +$27.2K ﹤0.01% 6674
2023
Q1
– Sell
-849
Closed -$21K – 10474
2022
Q4
$21K Buy
+849
New +$20.9K ﹤0.01% 7592

Other funds holding XC

UBS Group's XC Position: Q2 2026 in Review

UBS Group sold out of WisdomTree True Emerging Markets Fund (XC) in Q2 2026, closing a stake of 9 shares — an estimated $281 sold.

UBS Group first reported a position in XC in Q4 2022 and held it in 6 quarters. The position peaked at $51.4K in Q2 2025. 31 funds tracked by Wall St. Rank hold XC as of Q2 2026.

  • UBS Group reported no remaining WisdomTree True Emerging Markets Fund position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 9 WisdomTree True Emerging Markets Fund shares in Q2 2026, an estimated $281.
  • UBS Group first reported a position in WisdomTree True Emerging Markets Fund in Q4 2022 and held it in 6 quarters.
  • UBS Group's WisdomTree True Emerging Markets Fund position peaked at $51.4K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held WisdomTree True Emerging Markets Fund as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.